tiprankstipranks
Trending News
More News >
Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)
:2395
Japanese Market

Shin Nippon Biomedical Laboratories, Ltd. (2395) Revenue

Compare
2 Followers

Shin Nippon Biomedical Laboratories, Ltd. Revenue

Shin Nippon Biomedical Laboratories, Ltd. had a revenue of 6.48B in the quarter ending Jun 30, 2025, with -36.36%. This bring the company's revenue in the last twelve months to 33.34B, Decreased 2.86%. In the fiscal year ending Dec 31, 2024, Shin Nippon Biomedical Laboratories, Ltd. had annual revenue of 32.41B with 22.55% growth.
Revenue (ttm)
33.34B
Revenue Growth
28.06%
P/S Ratio
2.23
Revenue/Employee
¥22,246,951
Employees
1,457
Market Cap
¥72.15B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
32.41B5.96B+122.55%
Dec 31, 2023
26.45B1.36B+105.42%
Dec 31, 2022
25.09B7.34B+141.37%
Dec 31, 2021
17.75B2.64B+117.46%
Dec 31, 2020
15.11B549.46M+103.77%
Dec 31, 2019
14.56B-1.10B+92.99%
Dec 31, 2018
15.66B-941.87M+94.33%
Dec 31, 2017
16.60B-643.95M+96.27%
Dec 31, 2016
17.24B